Giulia Renda

18.6k total citations · 1 hit paper
111 papers, 3.5k citations indexed

About

Giulia Renda is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine and Surgery. According to data from OpenAlex, Giulia Renda has authored 111 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 86 papers in Cardiology and Cardiovascular Medicine, 25 papers in Internal Medicine and 22 papers in Surgery. Recurrent topics in Giulia Renda's work include Atrial Fibrillation Management and Outcomes (47 papers), Antiplatelet Therapy and Cardiovascular Diseases (33 papers) and Venous Thromboembolism Diagnosis and Management (25 papers). Giulia Renda is often cited by papers focused on Atrial Fibrillation Management and Outcomes (47 papers), Antiplatelet Therapy and Cardiovascular Diseases (33 papers) and Venous Thromboembolism Diagnosis and Management (25 papers). Giulia Renda collaborates with scholars based in Italy, United Kingdom and United States. Giulia Renda's co-authors include Raffaele De Caterina, Paul M. Ridker, Peter Libby, Tom Thurén, Marco Zimarino, Robert J. Glynn, Wolfgang Köenig, Jean MacFadyen, Paola Patrignani and Verena Walter and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and American Journal of Clinical Nutrition.

In The Last Decade

Giulia Renda

108 papers receiving 3.4k citations

Hit Papers

Modulation of the interleukin-6 signalling pathway and in... 2018 2026 2020 2023 2018 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Modulation of the interleukin-6 signalling pathway and incidence rates of atherosclerotic events and all-cause mortality: analyses from the Canakinumab Anti-Inflammatory Thrombosis Outcomes Study (CANTOS)
    2018 395 citations Paul M. Ridker, Peter Libby et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Giulia Renda Italy 27 1.9k 746 610 600 539 111 3.5k
Ettore Porreca Italy 36 1.1k 0.6× 662 0.9× 187 0.3× 453 0.8× 676 1.3× 132 4.0k
D Peetz Germany 25 1.5k 0.8× 603 0.8× 121 0.2× 516 0.9× 426 0.8× 68 3.1k
Gian Gastone Neri Serneri Italy 34 1.8k 1.0× 661 0.9× 370 0.6× 266 0.4× 574 1.1× 118 3.3k
Victor L. Serebruany United States 33 2.8k 1.5× 1.2k 1.6× 441 0.7× 307 0.5× 234 0.4× 114 3.8k
Zhimin Wang China 24 1.2k 0.6× 318 0.4× 189 0.3× 1.1k 1.8× 444 0.8× 127 3.0k
Panagiotis Korantzopoulos Greece 37 3.4k 1.8× 641 0.9× 136 0.2× 418 0.7× 618 1.1× 202 4.8k
Mette Charlot Denmark 20 986 0.5× 426 0.6× 281 0.5× 163 0.3× 174 0.3× 39 2.1k
Antonio González‐Pérez Spain 27 618 0.3× 678 0.9× 877 1.4× 361 0.6× 366 0.7× 69 2.8k
Eiichiro Yamamoto Japan 31 1.6k 0.8× 459 0.6× 171 0.3× 237 0.4× 650 1.2× 172 3.2k
Umberto Campia United States 33 1.7k 0.9× 679 0.9× 140 0.2× 378 0.6× 545 1.0× 86 3.6k

Countries citing papers authored by Giulia Renda

Since Specialization
Citations

This map shows the geographic impact of Giulia Renda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Giulia Renda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Giulia Renda more than expected).

Fields of papers citing papers by Giulia Renda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Giulia Renda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Giulia Renda. The network helps show where Giulia Renda may publish in the future.

Co-authorship network of co-authors of Giulia Renda

This figure shows the co-authorship network connecting the top 25 collaborators of Giulia Renda. A scholar is included among the top collaborators of Giulia Renda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Giulia Renda. Giulia Renda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bucciarelli, Valentina, Federica Moscucci, Susanna Sciomer, et al.. (2025). Gender and Sex-related differences in Type 2 Myocardial Infarction: the undervalued side of a neglected disease. Trends in Cardiovascular Medicine. 36(1). 27–34. 2 indexed citations
2.
Pastore, Maria Concetta, Anna Degiovanni, Leonardo Grisafi, et al.. (2024). Left Atrial Strain to Predict Postoperative Atrial Fibrillation in Patients Undergoing Coronary Artery Bypass Grafting. Circulation Cardiovascular Imaging. 17(1). e015969–e015969. 11 indexed citations
3.
Renda, Giulia, Valentina Bucciarelli, Paola Lanuti, et al.. (2024). Ex Vivo Antiplatelet Effects of Oral Anticoagulants. Journal of Cardiovascular Development and Disease. 11(4). 111–111. 2 indexed citations
4.
Ricci, Fabrizio, Mohammed Y Khanji, Cesare Mantini, et al.. (2023). Sex Differences in Heart Failure: What Do We Know?. Journal of Cardiovascular Development and Disease. 10(7). 277–277. 17 indexed citations
5.
Renda, Giulia, Marco Mennuni, Simona De Vecchi, et al.. (2023). Predictive Value of Echocardiographic Pulmonary to Left Atrial Ratio for In-Hospital Death in Patients with COVID-19. Diagnostics. 13(2). 224–224.
6.
Bucciarelli, Valentina, Anna Vittoria Mattioli, Susanna Sciomer, et al.. (2023). The Impact of Physical Activity and Inactivity on Cardiovascular Risk across Women’s Lifespan: An Updated Review. Journal of Clinical Medicine. 12(13). 4347–4347. 21 indexed citations
7.
Coccina, Francesca, Paola Borrelli, Anna M. Pierdomenico, et al.. (2022). Prediction of Masked Uncontrolled Hypertension Detected by Ambulatory Blood Pressure Monitoring. Diagnostics. 12(12). 3156–3156. 2 indexed citations
8.
Patti, Giuseppe, Giuseppe Di Martino, Fabrizio Ricci, et al.. (2021). Clustering of blood cell count abnormalities and future risk of death. European Journal of Clinical Investigation. 51(8). e13562–e13562. 2 indexed citations
9.
Morrone, Doralisa, Sonja Kroep, Fabrizio Ricci, et al.. (2020). Mortality Prediction of the CHA2DS2-VASc Score, the HAS-BLED Score, and Their Combination in Anticoagulated Patients with Atrial Fibrillation. Journal of Clinical Medicine. 9(12). 3987–3987. 15 indexed citations
10.
Calabrò, Paolo, Felice Gragnano, Arturo Cesaro, et al.. (2019). La trombosi atriale e auricolare sinistra nei pazienti con fibrillazione atriale: dalla fisiopatologia al trattamento. Giornale italiano di cardiologia. 20(6). 374–383. 1 indexed citations
11.
Renda, Giulia, Giuseppe Patti, Iréne Lang, et al.. (2019). Thrombotic and hemorrhagic burden in women: Gender-related issues in the response to antithrombotic therapies. International Journal of Cardiology. 286. 198–207. 21 indexed citations
12.
Patti, Giuseppe, Ladislav Pecen, Markus Lucerna, et al.. (2019). Net Clinical Benefit of Non-Vitamin K Antagonist vs Vitamin K Antagonist Anticoagulants in Elderly Patients with Atrial Fibrillation. The American Journal of Medicine. 132(6). 749–757.e5. 41 indexed citations
13.
Patti, Giuseppe, Ladislav Pecen, Markus Lucerna, et al.. (2018). Outcomes of anticoagulated patients with atrial fibrillation treated with or without antiplatelet therapy - A pooled analysis from the PREFER in AF and PREFER in AF PROLONGATON registries. International Journal of Cardiology. 270. 160–166. 18 indexed citations
14.
Siller‐Matula, Jolanta M., Ladislav Pecen, Giuseppe Patti, et al.. (2018). Heart failure subtypes and thromboembolic risk in patients with atrial fibrillation: The PREFER in AF - HF substudy. International Journal of Cardiology. 265. 141–147. 30 indexed citations
15.
Renda, Giulia, Marco Zimarino, Fabrizio Ricci, et al.. (2016). Efficacy and Safety of Non-Vitamin K Antagonist Oral Anticoagulants After Cardioversion for Nonvalvular Atrial Fibrillation. The American Journal of Medicine. 129(10). 1117–1123.e2. 16 indexed citations
16.
Caterina, Raffaele De, Ulrika Andersson, John H. Alexander, et al.. (2016). History of bleeding and outcomes with apixaban versus warfarin in patients with atrial fibrillation in the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation trial. American Heart Journal. 175. 175–183. 17 indexed citations
17.
Renda, Giulia, Giorgia Committeri, Marco Zimarino, et al.. (2015). Genetic determinants of cognitive responses to caffeine drinking identified from a double-blind, randomized, controlled trial. European Neuropsychopharmacology. 25(6). 798–807. 25 indexed citations
18.
Renda, Giulia, Marta Di Nicola, & Raffaele De Caterina. (2015). Net Clinical Benefit of Non-vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Phase III Atrial Fibrillation Trials. The American Journal of Medicine. 128(9). 1007–1014.e2. 29 indexed citations
19.
Ricci, Fabrizio, Giulia Renda, & Raffaele De Caterina. (2013). La terapia antitrombotica nella fibrillazione atriale: stato dell’arte e prospettive. Giornale italiano di cardiologia. 14(1). 21–34. 1 indexed citations
20.
Ridker, Paul M., Campbell P. Howard, Verena Walter, et al.. (2012). Effects of Interleukin-1β Inhibition With Canakinumab on Hemoglobin A1c, Lipids, C-Reactive Protein, Interleukin-6, and Fibrinogen. Circulation. 126(23). 2739–2748. 430 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ettore Porreca Breakdown of academic impact, for papers by D Peetz Breakdown of academic impact, for papers by Gian Gastone Neri Serneri Breakdown of academic impact, for papers by Victor L. Serebruany Breakdown of academic impact, for papers by Zhimin Wang Breakdown of academic impact, for papers by Panagiotis Korantzopoulos Breakdown of academic impact, for papers by Mette Charlot Breakdown of academic impact, for papers by Antonio González‐Pérez Breakdown of academic impact, for papers by Eiichiro Yamamoto Breakdown of academic impact, for papers by Umberto Campia
Rankless by CCL
2026